Jiangsu Collaborative Innovation Center of Biomedical Functional Materials, College of Chemistry and Materials Science, Nanjing Normal University, Nanjing, 210023, People's Republic of China.
College of Materials Science and Engineering, Nanjing Forestry University, Nanjing, 210037, People's Republic of China.
J Biomed Mater Res A. 2018 Aug;106(8):2131-2140. doi: 10.1002/jbm.a.36419. Epub 2018 Apr 17.
Expanded poly(tetrafluoroethylene) (ePTFE) has been widely used as a vascular graft material due to the fact that it is durable, porous, flexible, and inert. However, ePTFE grafts easily induce thrombosis, calcification and neointimal hyperplasia in small-diameter (<6 mm) graft bypass surgeries and thus cause surgical failure. Therefore, it is necessary to improve the in vitro and in vivo performances of ePTFE grafts. In this work, we first prepared a polyurethane/polyurethane nanoparticles (PU/PU-NPs) composite film by a simple cosedimentation method. Compared with the pure PU film, the blood compatibility and the cell compatibility of the PU/PU-NPs composite film were significantly improved. Then, we constructed a PU/PU-NPs/ePTFE vascular patch (PPVP) by coating PU and PU-NPs onto the surface of an ePTFE graft. PU-NP modification endowed the ePTFE graft with the nanopatterned surface similar to the luminal surface of a blood vessel. PU NPs and the structural likeness of the surface synergistically optimized the overall performance, and thus improved the blood and cell compatibilities, effectively inhibited platelet adhesion, enhanced cell attachment and proliferation, and facilitated the formation of endothelial tissue-endothelialization. The abdominal artery patched with PPVP was not blocked and the endothelialization was achieved 30 days after the implantation. All the results taken together indicate that PPVP may be a promising alternative for a vascular patch. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 2131-2140, 2018.
膨体聚四氟乙烯(ePTFE)由于其耐用、多孔、柔韧和惰性,已被广泛用作血管移植物材料。然而,ePTFE 移植物在小直径(<6mm)移植物旁路手术中容易引起血栓形成、钙化和新生内膜增生,从而导致手术失败。因此,有必要改善 ePTFE 移植物的体外和体内性能。在这项工作中,我们首先通过简单的共沉降法制备了一种聚氨酯/聚氨酯纳米粒子(PU/PU-NPs)复合膜。与纯 PU 膜相比,PU/PU-NPs 复合膜的血液相容性和细胞相容性得到了显著改善。然后,我们通过在 ePTFE 移植物表面涂覆 PU 和 PU-NPs 构建了一种 PU/PU-NPs/ePTFE 血管补片(PPVP)。PU-NP 改性使 ePTFE 移植物具有类似于血管腔表面的纳米图案表面。PU-NPs 和表面的结构相似性协同优化了整体性能,从而提高了血液和细胞相容性,有效抑制血小板黏附,增强细胞黏附和增殖,促进内皮组织形成-内皮化。用 PPVP 修补的腹动脉没有阻塞,植入 30 天后实现了内皮化。所有这些结果表明,PPVP 可能是一种有前途的血管补片替代物。©2018 年 Wiley 期刊出版公司。J 生物医学材料研究 A 部分:106A:2131-2140,2018 年。